Lipid Profile as Predictor of Adverse Maternal and Neonatal Outcomes: A Pilot Study
Recruitment Status: Recruiting
Start Date: July 29, 2022
End Date: June 30, 2023
The purpose of this study is to ascertain lipid profiles during pregnancy, specifically during the 24-28 week gestation and again near term at 36 weeks gestation. The research team are investigating whether lipid profiles can predict adverse maternal and neonatal outcomes.
Inclusion Criteria:
- Singleton pregnancy
- Ages 18-45
- Presentation to prenatal care by the 2nd trimester
- Prenatal care at Mount Sinai Hospital
- Anticipated delivery at Mount Sinai Hospital
Exclusion Criteria:
- Multiple gestations
- Preexisting hyperlipidemia
- Preexisting diabetes
- Delayed presentation to prenatal care after the 2nd trimester
5. Prenatal care or delivery outside of Mount Sinai Health System
-
Conditions:
- Hyperlipidemias